No Data
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
RBC Capital Remains a Buy on Mind Medicine (MNMD)
Mind Medicine Appoints Gregg Pratt Chief Regulatory, Quality Assurance Officer
Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading Into 2025?
RFK and the 'MAHA Trade': Vaccine Makers Down, Psychedelic Shares up
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) Market Cap Touched US$601m Last Week, Benefiting Both Retail Investors Who Own 41% as Well as Institutions